Rob Lowe opened up to PEOPLE about his late grandmother’s breast cancer journey and her success in a clinical trial. He’s now ...

Amazon.com, Nvidia, Tesla, and the rest of the Magnificent Seven stocks jump as the U.S. and China reach an agreement to ...

A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo ...

By Sukriti Gupta and Purvi Agarwal (Reuters) -European shares started the week on a positive note on Monday after the United ...

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this ...

Trump shared the anecdote as he signed an order Monday intended to drastically reduce the price Americans pay for pharmaceutical products — without naming the friend he was talking about.

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

Eli Lilly and Company and Purdue University are keeping their partnership alive beyond it’s previously expected years. In an ...

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

Trump's order seeks to ease regulations to compel more U.S. drug manufacturing. He also plans to assess tariffs on drug ...

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the ...